Shared decision making in dermatology: asking patients, ‘What is important to you?’
Open Access
- 15 April 2014
- journal article
- editorial
- Published by Wiley in British Journal of Dermatology
- Vol. 170 (4), 759-760
- https://doi.org/10.1111/bjd.12984
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- The effectiveness and safety of short‐contact dithranol therapy in paediatric psoriasis: a prospective comparison of regular day care and day care with telemedicineBritish Journal of Dermatology, 2014
- Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging studyBritish Journal of Dermatology, 2012
- Efficacy of apremilast in the treatment of moderate to severe psoriasis: a randomised controlled trialThe Lancet, 2012
- Shared Decision Making: A Model for Clinical PracticeJournal of General Internal Medicine, 2012
- Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque PsoriasisNew England Journal of Medicine, 2012
- Brodalumab, an Anti–Interleukin-17–Receptor Antibody for PsoriasisNew England Journal of Medicine, 2012
- Quantifying factors for the success of stratified medicineNature Reviews Drug Discovery, 2011
- Fumaric acid esters in the treatment of psoriasis - commentary on ‘Treatment of severe, recalcitrant, chronic plaque psoriasis with fumaric acid esters: a prospective study’ by Wain et al.British Journal of Dermatology, 2010
- Home versus outpatient ultraviolet B phototherapy for mild to severe psoriasis: pragmatic multicentre randomised controlled non-inferiority trial (PLUTO study)BMJ, 2009
- Shared decision-making in the medical encounter: What does it mean? (or it takes at least two to tango)Social Science & Medicine, 1997